• MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

Top Medical News

Presence of MOG-IgG in Children Meeting MS Criteria May Allude to Nontypical Disease Course

July 05, 2022

By Marco Meglio

All 12 of the children met diagnostic criteria for multiple sclerosis and were seropositive for MOG-IgG at baseline experienced a disease course different than typical MS through the observed time.

Biogen, Alectos Announce Licensing Agreement for Parkinson Disease GBA2 Inhibitor AL01811

July 05, 2022

By Marco Meglio

Alectos to receive a $15 million upfront payment from Biogen and is eligible to receive upward of $630 million pending the success of the collaboration and achieving future milestones for the investigational PD treatment.

FDA Action Update, June 2022: Approvals, Extended Reviews, and Clinical Holds

July 04, 2022

By Matt Hoffman

Catch up on any of the neurology news headlines you may have missed over the course of the last month, compiled all into one place by the NeurologyLive® team.

This Week on NeurologyLive® — July 4, 2022

July 04, 2022

By NeurologyLive® Staff

Here's what is coming soon to NeurologyLive®.

Genetic Associations Identified Between Midlife Depression and Alzheimer Disease

July 03, 2022

By Marco Meglio

Using a large-scale bank of participants, investigators found an association between Alzheimer disease polygenetic risk score and depression, which was not explained by presence of APOE ε4 allele.

Featured

Mind Moments podcast

Mind Moments Podcast

Click here to listen to Mind Moments™, a podcast from NeurologyLive® that brings you exclusive interviews with expert neurologists and clinicians.

NeuroVoices

NeuroVoices

Click here to read NeurologyLive®'s NeuroVoices series of in-depth, exclusive conversations with a variety of experts in the care and management of patients with neurologic diseases about topics in clinical care and therapeutic development.

ATMRD 2022

Coverage of the Advanced Therapeutics in Movement and Related Disorders Congress

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor.

Gold Standard Centers

Gold Standard Centers

Click here to check out the latest deep dive into examples of institutional success in medicine with our Gold Standard Centers feature series.

Brain Games

Brain Games

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics.

AHS 2022

Coverage of the American Headache Society Annual Scientific Meeting

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor.

Latest Videos

MS COVID-19/Vaccine Advice
Novel Oral Treatment Selection in RRMS
Comparing Reactive Microglia and Astrocytes in Secondary Progressive Multiple Sclerosis
Properly Assessing Cognition in Patients With Multiple Sclerosis: John DeLuca, PhD
Assessing Early Evidence, Long-Term Potential of EksoRN Robotic Exoskeleton: Francois Bethoux, MD
Ocrelizumab Reduces Thalamic Volume Loss, Cenobamate Shines in C017 Study, Trial of LRRK2 Inhibitor BIIB122 Commences
Regularly Measuring Cognition in MS, and Treating Cognitive Issues: John DeLuca, PhD
Benefits From the 2022 ATMRD Congress and Multidisciplinary Teams: Laxman Bahroo, DO
Rehabilitative Capabilities and Functions of EksoRN Robotic Exoskeleton in Multiple Sclerosis: Francois Bethoux, MD
Awareness of Botulinum Toxins in the Movement Disorder Landscape: Laxman Bahroo, DO
Involving Patients in the Conversation About Parkinson Disease Treatment Approaches: Jill Farmer, DO, MPH
Evobrutinib, BTK Inhibitors, and the Associations With Neurofilament Light: Jens Kuhle, MD, PhD
Using Primseq to Simplify the Complexities of Rehabilitation Intervention Dosing: Heidi Schambra, MD

Most Recent